Pfizer on Tuesday said it has begun early stage U.S. clinical trials of an investigational, oral antiviral drug for COVID-19.According to the company, the candidate “has demonstrated potent in vitro antiviral activity” against the virus that…
Copyright © 2024 | WordPress Theme by MH Themes